Rifadin For Infusion 600mg
Rifadin for Infusion is indicated for acutely ill patients who are unable to tolerate oral therapy, e.g. post-operative or comatose patients or patients in whom gastrointestinal absorption is impaired. Tuberculosis: Rifadin, used in combination with other active anti-tuberculosis drugs, is indicated in the treatment of all forms of tuberculosis, including fresh, advanced, chronic and drug-resistant cases. Rifadin is also effective against most atypical strains of Mycobacteria. Leprosy: Rifadin, used in combination with at least one other active anti-leprosy drug, is indicated in the management of multibacillary and paucibacillary leprosy to effect conversion of the infectious state to a non-infectious state. Other infections: Rifadin is indicated in the treatment of Brucellosis , Legionnaires Disease, and serious staphylococcal infections. To prevent emergence of resistant strains of the infecting organisms, Rifadin should be used in combination with another antibiotic appropriate for the infection.